HOME
ABOUT
CONSULTING
RESOURCES
USEFUL LINKS
CONTACT US

 

Resources

Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease

Systemic sclerosis-associated interstitial lung disease – proposed recommendations for future randomised clinical trials

Randomized, Prospective, Placebo-Controlled Trial of Bosentan in Interstitial Lung Disease Secondary to Systemic Sclerosis

Combined Analysis of Outcomes of Sitaxentan Treatment of Pulmonary Arterial Hypertension Associated With Connective Tissue Disease